Physician
Nephrology
Dr. Jose R. Weisinger, MD
|
|
Give Review
Jose Weisinger practices Nephrology. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (ASNF)". Jose R. Weisinger is also published. He has 55 publications published. The lastest publication: "Effect of recombinant human erythropoietin on endothelial cell apoptosis.' He accepts Medicare.
Publications
- Paricalcitol Downregulates Myocardial Renin-Angiotensin and Fibroblast Growth Factor Expression and Attenuates Cardiac Hypertrophy in Uremic Rats.
- Suppression of renin-angiotensin gene expression in the Kidney by paricalcitol.
- Bone Disease after renal transplantation.
- Increased osteoblastic activity and expression of receptor activator of NF-kappaB ligand in nonuremic Nephrotic syndrome.
- Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on Chronic hemodialysis.
- Outcomes associated with hypogonadism in women with chronic Kidney disease.
- Abnormalities of bone mineral density and bone Metabolism in Venezuelan patients with rheumatoid arthritis.
- Bone remodeling after Renal transplantation.
- Effects of raloxifene on bone Metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
- Selective estrogen receptor modulators in chronic renal Failure.
- The pathogenesis of osteodystrophy after Renal transplantation as detected by early alterations in bone remodeling.
- [Effect of hemodialysis on insulin secretion in islets isolated from mouse pancreas].
- Evidence that parathyroid hormone is not required for phosphate homeostasis in renal Failure.
- The Nephrotic syndrome: a complication of massive obesity.
- The effect of dialysis on true plasma glucose tolerance in uremia.
- [Need and demand of Kidneys for transplantation in Venezuela].
- Massive cerebral calcifications associated With increased renal phosphate reabsorption.
- Effect of metabolic Acidosis on the PTH receptor-adenylate cyclase system of canine kidney.
- Effects of cadmium on canine Renal cortical adenylate cyclase.
- Magnesium and Phosphorus.
- [Impact of the Hospital Coordinator Program on obtaining Kidneys for renal transplantation].
- Evidence that hemodialysis does not improve the glucose tolerance of patients with chronic renal Failure.
- Insulin and glucose Metabolism in renal insufficiency.
- In Chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase.
- Use of intrarenal needle manometry in Acute renal dysfunction following renal transplantation.
- Effects of Chronic metabolic alkalosis on Ca2+, PTH and 1,25(OH)2D3 in the rat.
- Insulin binding and glycolytic activity in erythrocytes from dialyzed and nondialyzed uremic patients.
- Latin American nephrology: scientific production and impact of the publications.
- Effect of Acidosis on PTH-dependent renal adenylate cyclase in phosphorus deprivation: role of G proteins.
- Access to medical information in Latin America.
- Role of hormone replacement in the management of osteoporosis in haemodialysed women: perspectives for the future.
- [Safety in the switching traditional cyclosporin to microemulsion cyclosporin in stable Renal transplant patients: cooperative study].
- Effect of recombinant human erythropoietin on endothelial cell apoptosis.
- Decreased bone mass despite long-term estrogen replacement therapy in young women With Turner's syndrome and previously normal bone density.
- Bone loss in hypercalciuria: cause or consequence?
- Regulation of 1,25-dihydroxyvitamin D3 by Calcium in the parathyroidectomized, parathyroid hormone-replete rat.
- New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone.
- Occult rejection in Renal allografts: preconversion biopsies and postconversion rejection in recipients converted from cyclosporine to azathioprine alone at 6 to 12 mo...
- [Role of bones in the physiopathology of idiopathic hypercalciuria: effect of amino-bisphosphonate alendronate].
- Bone mineral density of prepubertal age girls With Turner''s syndrome while on growth hormone therapy.
- Bone Disease in patients with long-term renal transplantation and normal renal function.
- Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent Diabetes mellitus followed longitudinally.
- Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 Diabetes mellitus.
- Decreased trabecular bone mineral density in children With idiopathic short stature: normalization of bone density and increased bone turnover after 1 year of growth h...
- What are the bone lesions in patients With more than four years of a functioning renal transplant?
- Changes in bone mineral density, growth velocity and Renal function of prepubertal uremic children during growth hormone treatment.
- Possible role of cytokines on the bone Mineral loss in idiopathic hypercalciuria.
- Role of persistent amenorrhea in bone mineral Metabolism of young hemodialyzed women.
- Bone Disease in hypercalciuria: a new form of osteodystrophy?
- The effect of short- and long-term growth hormone treatment on bone mineral density and bone Metabolism of prepubertal children with idiopathic short stature: a 3-year...
- Reduced bone mass in children With idiopathic hypercalciuria and in their asymptomatic mothers.
- Osteoporosis in chronic Kidney disease.
- Postmenopausal osteoporosis in the dialysis patient.
- Renal function and bisphosphonate safety.
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Amyloidosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- AvMed
- Blue Card PPO
- Blue Care HMO
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Employer Group Open Access HMO
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Select HMO
- Medica
- Medicaid
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (ASNF)
Hospital
-
Baptist Hospital of Miami -
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1891965778 | |
| NPPES Provider LastName | WEISINGER | |
| NPPES Provider FirstName | JOSE | |
| NPPES Provider ZIPCode | 331762288 | |
| NPPES Provider State | FL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 616.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891965778 |
| Last Name Of The Provider | WEISINGER |
| First Name Of The Provider | JOSE |
| View All |
Similar Doctors
|
Dr. Gaspar A. Barreto Torrella, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael T. Lemont, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cliff Glasser, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dollie F. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor M. Richards, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis M. Ortega, MD |
|
|
Dr. Jose J. Wenger, MD |
|
|
Dr. Victor Lopez De Mendoza, MD |